洁特生物(688026) - 2022 Q1 - 季度财报

Revenue and Profit - Revenue for Q1 2022 was CNY 190,362,813.69, representing a year-over-year increase of 9.42%[2] - Net profit attributable to shareholders decreased by 14.64% to CNY 41,015,898.04 compared to the same period last year[2] - Basic and diluted earnings per share were both CNY 0.41, down 14.58% year-over-year[2] - Net profit for Q1 2022 was ¥41,015,898.04, a decrease of 14.66% from ¥48,051,641.98 in Q1 2021[14] - Earnings per share for Q1 2022 was ¥0.41, down from ¥0.48 in Q1 2021[15] Expenses and Costs - R&D expenses totaled CNY 9,684,707.76, an increase of 102.82% year-over-year, accounting for 5.09% of revenue[2][5] - Total operating costs for Q1 2022 were ¥143,124,159.20, up from ¥112,539,775.03 in Q1 2021, representing a 27.19% increase[14] - Research and development expenses for Q1 2022 were ¥9,684,707.76, significantly higher than ¥4,775,140.09 in Q1 2021, marking an increase of 102.56%[14] - The company reported a financial expense of ¥1,861,898.50 in Q1 2022, compared to a financial income of ¥1,476,820.70 in Q1 2021[14] Assets and Liabilities - Total assets at the end of Q1 2022 were CNY 1,214,895,768.46, up 2.92% from the end of the previous year[3] - The company's cash and cash equivalents decreased to RMB 202,944,762.76 from RMB 263,468,195.75, representing a decline of about 22.9%[9] - Accounts receivable increased to RMB 150,278,082.51 from RMB 141,090,377.22, showing a growth of approximately 6.5%[9] - Inventory rose to RMB 128,398,777.17 from RMB 123,118,175.57, indicating an increase of about 4.3%[9] - Non-current assets totaled RMB 690,164,465.88, up from RMB 610,492,350.22, marking an increase of approximately 13.1%[10] - The company's total liabilities included accounts payable of RMB 45,596,561.09, down from RMB 67,360,606.60, a decrease of about 32.3%[10] - The company reported a decrease in other payables from RMB 1,822,979.80 to RMB 10,381,334.39, reflecting a significant increase of approximately 471.5%[10] - The company’s total current assets were reported at RMB 524,731,302.58, down from RMB 569,962,532.45, reflecting a decrease of approximately 7.9%[9] - Total liabilities decreased to ¥196,987,467.94 in Q1 2022 from ¥208,635,517.48 in Q1 2021, a reduction of 5.88%[14] - Total equity attributable to shareholders increased to ¥1,017,908,300.52 in Q1 2022 from ¥971,819,365.19 in Q1 2021, an increase of 4.73%[14] Cash Flow - The net cash flow from operating activities was CNY 20,813,635.51, a significant increase from the previous year's negative cash flow[5] - Cash received from sales of goods and services in Q1 2022 was ¥187,269,990.41, compared to ¥138,148,919.16 in Q1 2021, reflecting a growth of 35.51%[17] - Total cash inflow from operating activities reached $212,236,160.54, while cash outflow was $191,422,525.03, resulting in a net increase of $20,813,635.51[18] - Cash flow from investing activities was negative at -$77,178,782.19, compared to -$54,054,106.13 in the same period last year, reflecting increased investment expenditures[18] - Cash flow from financing activities resulted in a net outflow of -$2,469,321.10, a decrease from a net inflow of $3,058,113.22 in the previous year[19] - The company received $3,034,654.16 in tax refunds, contributing to the overall cash inflow from operating activities[18] - Cash paid to employees was $34,266,794.49, an increase from $30,462,781.41 in the previous year, indicating higher personnel costs[18] - Cash paid for taxes amounted to $8,790,573.34, compared to $7,684,658.77 in the same period last year, reflecting an increase in tax obligations[18] Investments and Capital Expenditures - The company has ongoing investments in long-term equity amounting to RMB 49,807,269.40, compared to RMB 30,735,681.62 previously, indicating a growth of approximately 62.1%[10] - The company invested $57,178,782.19 in fixed assets, up from $50,054,106.13 in the previous year, indicating ongoing capital expenditures[18] Shareholder Information - The total number of common shareholders at the end of the reporting period was 4,615[6] - Shareholders' equity attributable to the parent company increased by 4.74% to CNY 1,017,908,300.52[3] Miscellaneous - The company reported non-recurring gains of CNY 1,449,082.21 after tax[4] - The weighted average return on equity decreased by 1.73 percentage points to 4.12%[2] - Deferred income tax liabilities remained stable at ¥1,961,645.33 in both Q1 2022 and Q1 2021[14] - The impact of exchange rate changes on cash and cash equivalents was -$1,688,965.21, compared to -$118,947.16 in the previous year, highlighting currency fluctuations' effect on cash reserves[19]